For patients with rare diseases who use plasma-derived medicines, access can’t wait. PPTA’s work helps clear barriers and streamline regulatory pathways so plasma-derived medicines can reach patients faster. Learn from PPTA’s James Knowles, Senior Director, Global Regulatory Policy, how regulatory policy directly impacts access to lifesaving treatments in this video.